Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: J Pharmacol Exp Ther. 2008 Dec 9;328(3):715–722. doi: 10.1124/jpet.108.147330

Figure 7. Disorazole C1 causes premature senescence.

Figure 7

A549 cells were treated for 7 days with vehicle (DMSO), doxorubicin (DOX, 50 nM), the inactive analog 010A (10 nM), discodermolide (DISCO, 25 nM) vinblastine (VBL, 2 nM), or disorazole C1 (C1, 1–10 nM) followed by β-galactosidase staining.